REGN7257
R7257-RAA-1947
Phase 1 small_molecule terminated
Quick answer
REGN7257 for Severe Aplastic Anemia (SAA) is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Severe Aplastic Anemia (SAA)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated